• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

茶碱整片与半片缓释片的相对生物利用度

Comparative bio-availability of theophylline whole and halved sustained-release tablets.

作者信息

Müller F O, Hundt H K, Luus H G, van Dyk M, Groenewoud G, van der Meer M J, Steinijans V W

出版信息

S Afr Med J. 1987 Aug 1;72(3):175-8.

PMID:3299763
Abstract

In a randomised, multiple-dose, cross-over study in 14 healthy volunteers, plasma theophylline concentrations were compared during a 12-hour dosing interval after repeated administration of theophylline (Euphyllin Retard; Byk Gulden) as whole and halved tablets. Bio-availability of theophylline from the halved tablets relative to the whole tablets was: 116% (100%, 134%) for the extent of absorption as judged by the area under the concentration time curve (AUC) and 115% (99%, 135%) for the rate of absorption as judged by maximum concentration (Cmax). The confidence levels for the 80-120% bio-equivalence range were 72% (AUC) and 76% (Cmax), those for the 80 and 125% range were 91% (AUC) and 91% (Cmax). The plateau times T75% Cmax, which characterise the sustained-released properties, were 8.5 +/- 2.9 hours (halved) and 8.3 +/- 2.5 hours (whole) during the 12-hour dosing interval. It is concluded that no clinically relevant deviations in steady-state plasma theophylline concentration and sustained-release properties are likely to result from breaking (halving) the film-coated tablets.

摘要

在一项针对14名健康志愿者的随机、多剂量、交叉研究中,比较了在重复服用氨茶碱(长效优喘平;拜耳先灵)整片和半片后的12小时给药间隔期间的血浆氨茶碱浓度。相对于整片,半片氨茶碱的生物利用度为:以浓度-时间曲线下面积(AUC)判断的吸收程度为116%(100%,134%),以最大浓度(Cmax)判断的吸收速率为115%(99%,135%)。80 - 120%生物等效性范围的置信水平,AUC为72%,Cmax为76%;80%至125%范围的置信水平,AUC为91%,Cmax为91%。在12小时给药间隔期间,表征缓释特性的达峰时间T75% Cmax,半片为8.5±2.9小时,整片为8.3±2.5小时。得出的结论是,掰开(切成半片)薄膜包衣片不太可能导致稳态血浆氨茶碱浓度和缓释特性出现临床相关偏差。

相似文献

1
Comparative bio-availability of theophylline whole and halved sustained-release tablets.茶碱整片与半片缓释片的相对生物利用度
S Afr Med J. 1987 Aug 1;72(3):175-8.
2
Comparison of steady state serum theophylline concentrations in healthy volunteers after dosing with Euphyllin retard and PulmiDur.健康志愿者服用长效氨茶碱和 PulmiDur 后稳态血清茶碱浓度的比较。
Int J Clin Pharmacol Ther Toxicol. 1987 Jun;25(6):342-6.
3
Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.来自缓释氨茶碱制剂(优喘平缓释片)的茶碱生物利用度——单次和多次口服给药后的血浆水平
Int J Clin Pharmacol Ther Toxicol. 1981 May;19(5):223-7.
4
Dissolution and bioavailability studies of whole and halved sustained-release theophylline tablets.整片与半片缓释茶碱片的溶出度及生物利用度研究
J Pharm Sci. 1982 May;71(5):505-11. doi: 10.1002/jps.2600710507.
5
Absorption properties of two theophylline sustained-release products in smokers.两种茶碱缓释制剂在吸烟者中的吸收特性
S Afr Med J. 1984 Jun 30;65(26):1045-8.
6
Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
Int J Clin Pharmacol Ther Toxicol. 1984 Nov;22(11):621-5.
7
The relation of product formulation to absorption of oral theophylline.产品配方与口服茶碱吸收的关系。
N Engl J Med. 1978 Oct 19;299(16):852-7. doi: 10.1056/NEJM197810192991603.
8
Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.评估3种不同饮食对2种缓释茶碱基质片生物利用度的影响。
Int J Clin Pharmacol Ther. 1997 Dec;35(12):565-71.
9
Absorption of theophylline from conventional and sustained-release tablets.茶碱在普通片剂和缓释片剂中的吸收情况。
Eur J Respir Dis Suppl. 1980;109:54-60.
10
The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.一种新型儿科缓释茶碱片以整片或分服形式给药时的绝对生物利用度。
Int J Clin Pharmacol Ther Toxicol. 1984 Sep;22(9):506-10.

引用本文的文献

1
Concerns regarding tablet splitting: a systematic review.关于片剂分割的担忧:一项系统评价
BJGP Open. 2022 Sep 28;6(3). doi: 10.3399/BJGPO.2022.0001. Print 2022 Sep.